Category: Cardiovascular Disease

Heart Failure: What’s New? What’s Coming?

February 18, 2021

February 14-20 is designated as Heart Failure Awareness Week. It is a great time to review our evolving treatment paradigm in the management of patients with heart failure, and to look ahead hopefully to the addition of new strategies under development.

Rethinking Rhythm Control in AF: Sooner Rather than Later?

September 8, 2020

One of the several noteworthy trials presented at the virtual ESC Congress was the EAST-AFNET 4NET 4 trial, which was published concurrently in the New England Journal of Medicine. 

Early News from the Virtual ESC Congress EXPLORER-HM

August 31, 2020

Lacopo Olivotto, MD, presented the results of the EXPLORER-HCM trial, which examined mavacamten as an alternative to surgical or catheter-based interventions to treat obstructive hypertrophic cardiomyopathy (HCM).

Tips to Address the Challenges of non-COVID Care in the Time of a Pandemic

August 10, 2020

In addition to managing the enormous burden of COVID-19 infection and mortality, clinicians are also charged with how we can best provide ongoing regular care for non-COVID patients.

COVID-19: Impact on Cardiovascular Disease Care, Lifelong Learning, and Research

July 27, 2020

In a special report last week, the European Heart Journal spoke to cardiovascular disease (CVD) thought leaders across the globe to gather their insights on the impact of the COVID-19 pandemic on cardiovascular care.

1 of 1